SCHEDULE 13G

Nektar Therapeutics

Common Stock, $0.0001 par value · CUSIP: 640268306

Event date: 2025-07-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• BIOTECHNOLOGY VALUE FUND L P

  Shares: 661,758.00 · Class: 3.8%

• BVF I GP LLC

  Shares: 661,758.00 · Class: 3.8%

• BIOTECHNOLOGY VALUE FUND II LP

  Shares: 517,813.00 · Class: 3.0%

• BVF II GP LLC

  Shares: 517,813.00 · Class: 3.0%

• Biotechnology Value Trading Fund OS LP

  Shares: 71,367.00 · Class: 0.4%

• BVF Partners OS Ltd.

  Shares: 71,367.00 · Class: 0.4%

• BVF GP HOLDINGS LLC

  Shares: 1,179,571.00 · Class: 6.8%

• BVF PARTNERS L P/IL

  Shares: 1,276,595.00 · Class: 7.4%

• BVF INC/IL

  Shares: 1,276,595.00 · Class: 7.4%

• LAMPERT MARK N

  Shares: 1,276,595.00 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.